We are live on ! Find out more
SM

SG3 Management Portfolio holdings

AUM $6.45K
1-Year Est. Return 61.81%
This Fund
S&P 500
This Quarter Est. Return
+2.7%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
AUM
$746M
AUM Growth
-$106M
Cap. Flow
-$67.1M
Cap. Flow %
-9%
Top 10 Hldgs %
44.28%
Holding
510
New
122
Increased
34
Reduced
59
Closed
238

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$49.5M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$21.8M
3
DIS icon
Walt Disney
DIS
+$16.1M
4
MSFT icon
Microsoft
MSFT
+$11M
5
TSM icon
TSMC
TSM
+$8.27M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 7.31%
2 Communication Services 4.95%
3 Technology 3.75%
4 Energy 1.57%
5 Healthcare 1.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AZN icon
301
CALL
AstraZeneca
AZN
$269B
-46,950
Closed -$6.2M
BEKE icon
302
KE Holdings
BEKE
$17.7B
-5,000
Closed -$90K
BEKE icon
303
PUT
KE Holdings
BEKE
$17.7B
-30,000
Closed -$539K
BHC icon
304
Bausch Health
BHC
$1.75B
-770,500
Closed -$5.35M
BHC icon
305
PUT
Bausch Health
BHC
$1.75B
-770,500
Closed -$6.44M
BILI icon
306
PUT
Bilibili
BILI
$7.75B
-88,600
Closed -$2.27M
BKR icon
307
CALL
Baker Hughes
BKR
$58.3B
-12,000
Closed -$346K
BKR icon
308
PUT
Baker Hughes
BKR
$58.3B
-30,000
Closed -$866K
BLMN icon
309
CALL
Bloomin' Brands
BLMN
$754M
-300,000
Closed -$4.99M
BLMN icon
310
PUT
Bloomin' Brands
BLMN
$754M
-240,000
Closed -$3.99M
BMRN icon
311
BioMarin Pharmaceuticals
BMRN
$11.9B
-10,300
Closed -$917K
BMRN icon
312
PUT
BioMarin Pharmaceuticals
BMRN
$11.9B
-25,000
Closed -$2.07M
BNTX icon
313
BioNTech
BNTX
$23.5B
-3,000
Closed -$459K
BNTX icon
314
PUT
BioNTech
BNTX
$23.5B
-35,000
Closed -$5.22M
BOX icon
315
Box
BOX
$4.49B
-5,000
Closed -$126K
BP icon
316
CALL
BP
BP
$112B
-13,000
Closed -$369K
BRDG
317
CALL
DELISTED
Bridge Investment Group
BRDG
-25,900
Closed -$377K
BRK.B icon
318
PUT
Berkshire Hathaway Class B
BRK.B
$1.1T
-2,100
Closed -$573K
CCCC icon
319
CALL
C4 Therapeutics
CCCC
$389M
-77,600
Closed -$585K
CL icon
320
CALL
Colgate-Palmolive
CL
$74.8B
-225,000
Closed -$18M
CLDX icon
321
CALL
Celldex Therapeutics
CLDX
$2.94B
-26,000
Closed -$701K
CLDX icon
322
PUT
Celldex Therapeutics
CLDX
$2.94B
-18,000
Closed -$485K
CMPS
323
Compass Pathways
CMPS
$1.47B
-2,000
Closed -$22K
CMPS
324
PUT
Compass Pathways
CMPS
$1.47B
-2,400
Closed -$26K
COP icon
325
ConocoPhillips
COP
$144B
-18,000
Closed -$1.62M

Similar funds

SG3 Management's Q3 2022 Portfolio in Review

As of Q3 2022, SG3 Management held 510 positions worth $746M, down 12% from $852M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

SG3 Management withdrew a net $67.1M in Q3 2022, closing 238 positions and reducing 59 holdings. Its most notable exit was KraneShares CSI China Internet ETF, an estimated $6.55M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 7.3% of assets, up from 0.21% a quarter earlier, followed by Communication Services and Technology.

Against the trend, SG3 Management opened a new position in Tesla worth $47M.

  • SG3 Management's largest Q3 2022 buy was Tesla: 177,200 shares worth $47M.
  • SG3 Management added most to Apellis Pharmaceuticals in Q3 2022, an estimated $2.3M increase.
  • SG3 Management's biggest Q3 2022 reduction was LivaNova, cutting an estimated $1.29M.
  • SG3 Management fully exited KraneShares CSI China Internet ETF in Q3 2022, selling an estimated $6.55M.
  • SG3 Management's ten largest holdings make up 44% of its $746M portfolio in Q3 2022.
  • SG3 Management opened 122 new positions and closed 238 in Q3 2022.
  • SG3 Management's portfolio value fell 12% quarter-over-quarter to $746M.

Based on SG3 Management's 13F filing for Q3 2022, filed 14 Nov 2022.